PERSPECTA

News from every angle

← Back to headlines

Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?

Analysts are projecting a significant upside of over 180% for Allogene Therapeutics (ALLO), indicating strong confidence in the company's future growth and stock performance. The article explores the reasons behind this optimistic forecast.

12 Apr, 21:49 — 12 Apr, 21:49
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual7h ago

Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?

Read full article →

Related Stories

Cognitive Behavioral Therapy Helps with Depression, Phobias, and Anxiety

just now

Yuhan's Gaucher Drug Candidate Receives FDA Orphan Status

23m ago

Investigation Reveals Global Divide in Access to Merck's Keytruda Drug

25m ago

Deadly Stampede at Haitian Mountaintop Fortress Kills At Least 25

25m ago